In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Latest
Food Lion donates $50,000 to support Venezuela Earthquake Relief
Donation will help nourish families impacted by the disaster
Costco reports double-digit June sales growth
Net sales rose 10.6% in June as digitally enabled sales continued to outpace overall growth and the retailer increased its quarterly dividend.
CHPA welcomes Missouri law expanding OTC cold and allergy med access
CHPA said the legislation will help consumers access the medications they need while preserving measures to prevent illegal diversion.
7-Eleven marks 60 Years of Slurpee® tomorrow with free drinks and a new flavor
Customers can sip, celebrate and stop by participating stores nationwide for a free small Slurpee drink on July 11